Literature DB >> 26936603

The HIV Protein gp120 Alters Mitochondrial Dynamics in Neurons.

Valeria Avdoshina1, Jerel Adam Fields2, Paul Castellano3, Simona Dedoni1, Guillermo Palchik4, Margarita Trejo2, Anthony Adame2, Edward Rockenstein2, Eliseo Eugenin3, Eliezer Masliah2,5, Italo Mocchetti1.   

Abstract

Neurotoxicity of human immunodeficiency virus-1 (HIV) includes synaptic simplification and neuronal apoptosis. However, the mechanisms of HIV-associated neurotoxicity remain unclear, thus precluding an effective treatment of the neurological complications. The present study was undertaken to characterize novel mechanisms of HIV neurotoxicity that may explain how HIV subjects develop neuronal degeneration. Several neurodegenerative disorders are characterized by mitochondrial dysfunction; therefore, we hypothesized that HIV promotes mitochondrial damage. We first analyzed brains from HIV encephalitis (HIVE) by electron microscopy. Several sections of HIVE subjects contained enlarged and damaged mitochondria compared to brains from HIV subjects with no neurological complications. Similar pathologies were observed in mice overexpressing the HIV protein gp120, suggesting that this viral protein may be responsible for mitochondrial pathology found in HIVE. To gain more information about the cellular mechanisms of gp120 neurotoxicity, we exposed rat cortical neurons to gp120 and we determined cellular oxygen consumption rate, mitochondrial distribution, and trafficking. Our data show that gp120 evokes impairment in mitochondrial function and distribution. These data suggest that one of the mechanisms of HIV neurotoxicity includes altered mitochondrial dynamics in neurons.

Entities:  

Keywords:  Fis-1; Gp120ADA; HIVE; Mitochondrial respiration; Oxygen consumption; Tom 20

Mesh:

Substances:

Year:  2016        PMID: 26936603      PMCID: PMC4821687          DOI: 10.1007/s12640-016-9608-6

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  57 in total

1.  Axonal transport of human immunodeficiency virus type 1 envelope protein glycoprotein 120 is found in association with neuronal apoptosis.

Authors:  Alessia Bachis; Sadia A Aden; Rachel L Nosheny; Peter M Andrews; Italo Mocchetti
Journal:  J Neurosci       Date:  2006-06-21       Impact factor: 6.167

Review 2.  Cell death in HIV dementia.

Authors:  M P Mattson; N J Haughey; A Nath
Journal:  Cell Death Differ       Date:  2005-08       Impact factor: 15.828

3.  Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease.

Authors:  Ulziibat P Shirendeb; Marcus J Calkins; Maria Manczak; Vishwanath Anekonda; Brett Dufour; Jodi L McBride; Peizhong Mao; P Hemachandra Reddy
Journal:  Hum Mol Genet       Date:  2011-10-13       Impact factor: 6.150

Review 4.  HIV's double strike at the brain: neuronal toxicity and compromised neurogenesis.

Authors:  Marcus Kaul
Journal:  Front Biosci       Date:  2008-01-01

5.  Levels of human Fis1 at the mitochondrial outer membrane regulate mitochondrial morphology.

Authors:  Diana Stojanovski; Olga S Koutsopoulos; Koji Okamoto; Michael T Ryan
Journal:  J Cell Sci       Date:  2004-03-01       Impact factor: 5.285

6.  HIV associated neurodegeneration requires p53 in neurons and microglia.

Authors:  Gwenn A Garden; Weiqun Guo; Suman Jayadev; Christina Tun; Stephanie Balcaitis; Jo Choi; Thomas J Montine; Thomas Möller; Richard S Morrison
Journal:  FASEB J       Date:  2004-05-20       Impact factor: 5.191

7.  Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons.

Authors:  Diane T W Chang; Gordon L Rintoul; Sruthi Pandipati; Ian J Reynolds
Journal:  Neurobiol Dis       Date:  2006-02-09       Impact factor: 5.996

8.  Mitochondrial fission and cristae disruption increase the response of cell models of Huntington's disease to apoptotic stimuli.

Authors:  Veronica Costa; Marta Giacomello; Roman Hudec; Raffaele Lopreiato; Gennady Ermak; Dmitri Lim; Walter Malorni; Kelvin J A Davies; Ernesto Carafoli; Luca Scorrano
Journal:  EMBO Mol Med       Date:  2010-12       Impact factor: 12.137

9.  Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity.

Authors:  Wenjun Song; Jin Chen; Alejandra Petrilli; Geraldine Liot; Eva Klinglmayr; Yue Zhou; Patrick Poquiz; Jonathan Tjong; Mahmoud A Pouladi; Michael R Hayden; Eliezer Masliah; Mark Ellisman; Isabelle Rouiller; Robert Schwarzenbacher; Blaise Bossy; Guy Perkins; Ella Bossy-Wetzel
Journal:  Nat Med       Date:  2011-02-20       Impact factor: 53.440

Review 10.  Neuropathology of HAND With Suppressive Antiretroviral Therapy: Encephalitis and Neurodegeneration Reconsidered.

Authors:  Benjamin B Gelman
Journal:  Curr HIV/AIDS Rep       Date:  2015-06       Impact factor: 5.071

View more
  43 in total

1.  Mitochondrial biogenesis is altered in HIV+ brains exposed to ART: Implications for therapeutic targeting of astroglia.

Authors:  Mary K Swinton; Aliyah Carson; Francesca Telese; Ana B Sanchez; Benchawanna Soontornniyomkij; Leila Rad; Isabella Batki; Brandi Quintanilla; Josué Pérez-Santiago; Cristian L Achim; Scott Letendre; Ronald J Ellis; Igor Grant; Anne N Murphy; Jerel Adam Fields
Journal:  Neurobiol Dis       Date:  2019-06-22       Impact factor: 5.996

2.  Rubella Viruses Shift Cellular Bioenergetics to a More Oxidative and Glycolytic Phenotype with a Strain-Specific Requirement for Glutamine.

Authors:  Nicole C Bilz; Kristin Jahn; Mechthild Lorenz; Anja Lüdtke; Judith M Hübschen; Henriette Geyer; Annette Mankertz; Denise Hübner; Uwe G Liebert; Claudia Claus
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

Review 3.  Involvement of organelles and inter-organellar signaling in the pathogenesis of HIV-1 associated neurocognitive disorder and Alzheimer's disease.

Authors:  Nabab Khan; Norman J Haughey; Avindra Nath; Jonathan D Geiger
Journal:  Brain Res       Date:  2019-08-16       Impact factor: 3.252

Review 4.  HIV-1 infection alters energy metabolism in the brain: Contributions to HIV-associated neurocognitive disorders.

Authors:  Bianca Cotto; Kalimuthusamy Natarajanseenivasan; Dianne Langford
Journal:  Prog Neurobiol       Date:  2019-05-18       Impact factor: 11.685

5.  Mitochondrial Impairment in Well-Suppressed Children with Perinatal HIV-Infection on Antiretroviral Therapy.

Authors:  Jing Shen; Afaaf Liberty; Stephanie Shiau; Renate Strehlau; Sheila Pierson; Faeezah Patel; LiQun Wang; Megan Burke; Avy Violari; Ashraf Coovadia; Elaine J Abrams; Stephen Arpadi; Marc Foca; Louise Kuhn
Journal:  AIDS Res Hum Retroviruses       Date:  2019-07-15       Impact factor: 2.205

Review 6.  An Overview of Human Immunodeficiency Virus Type 1-Associated Common Neurological Complications: Does Aging Pose a Challenge?

Authors:  Anantha Ram Nookala; Joy Mitra; Nitish S Chaudhari; Muralidhar L Hegde; Anil Kumar
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

7.  Endocytic Trafficking of HIV gp120 is Mediated by Dynamin and Plays a Role in gp120 Neurotoxicity.

Authors:  Erin D Wenzel; Alessia Bachis; Valeria Avdoshina; Francesca Taraballi; Ennio Tasciotti; Italo Mocchetti
Journal:  J Neuroimmune Pharmacol       Date:  2017-03-27       Impact factor: 4.147

Review 8.  HIV-associated neurodegeneration: exploitation of the neuronal cytoskeleton.

Authors:  Erin D Wenzel; Valeria Avdoshina; Italo Mocchetti
Journal:  J Neurovirol       Date:  2019-03-08       Impact factor: 2.643

Review 9.  Human Immunodeficiency Virus Promotes Mitochondrial Toxicity.

Authors:  Summer J Rozzi; Valeria Avdoshina; Jerel A Fields; Margarita Trejo; Hoai T Ton; Gerard P Ahern; Italo Mocchetti
Journal:  Neurotox Res       Date:  2017-07-10       Impact factor: 3.911

10.  Human Immunodeficiency Virus Type 1 gp120 and Tat Induce Mitochondrial Fragmentation and Incomplete Mitophagy in Human Neurons.

Authors:  Carmen Teodorof-Diedrich; Stephen A Spector
Journal:  J Virol       Date:  2018-10-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.